Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| 1 |
Invesco QQQ Trust
QQQ
|
+$883M |
| 2 |
Boeing
BA
|
+$345M |
| 3 |
Salesforce
CRM
|
+$344M |
| 4 |
DexCom
DXCM
|
+$301M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$253M |
Top Sells
| 1 |
DRE
Duke Realty Corp.
DRE
|
+$779M |
| 2 |
Chevron
CVX
|
+$585M |
| 3 |
Home Depot
HD
|
+$264M |
| 4 |
Chubb
CB
|
+$263M |
| 5 |
PepsiCo
PEP
|
+$263M |
Sector Composition
| 1 | Technology | 16.53% |
| 2 | Healthcare | 15.07% |
| 3 | Financials | 14.94% |
| 4 | Industrials | 11.6% |
| 5 | Consumer Discretionary | 10.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CDMO
3976
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $228K | ﹤0.01% |
16,574
-11,091
| -40% | -$153K |
|
|
HYZN
3977
DELISTED
Hyzon Motors Inc. Class A Common Stock
HYZN
| $228K | ﹤0.01% |
2,936
-2,112
| -42% | -$164K |
|
|
MSAC
3978
DELISTED
Medicus Sciences Acquisition Corp. Class A Ordinary Share
MSAC
| $227K | ﹤0.01% |
22,536
| – | – |
|
3979
Acrivon Therapeutics
ACRV
$52.2M
| $226K | ﹤0.01% |
+19,639
| New | +$226K |
|
3980
Cardlytics
CDLX
$134M
| $226K | ﹤0.01% |
39,035
-90,625
| -70% | -$525K |
|
3981
Global Industrial
GIC
$1.38B
| $226K | ﹤0.01% |
9,604
-12,992
| -57% | -$306K |
|
3982
Tenaya Therapeutics
TNYA
$218M
| $226K | ﹤0.01% |
112,193
+15,168
| +16% | +$30.6K |
|
3983
AYTU BioPharma
AYTU
$21.7M
| $225K | ﹤0.01% |
59,498
+39,006
| +190% | +$148K |
|
3984
Bar Harbor Bankshares
BHB
$535M
| $225K | ﹤0.01% |
7,023
-9,054
| -56% | -$290K |
|
3985
Krispy Kreme
DNUT
$596M
| $225K | ﹤0.01% |
+21,787
| New | +$225K |
|
3986
Pegasystems
PEGA
$10.2B
| $224K | ﹤0.01% |
13,074
-27,800
| -68% | -$476K |
|
3987
ICU Medical
ICUI
$3.23B
| $223K | ﹤0.01% |
+1,418
| New | +$223K |
|
3988
MiMedx Group
MDXG
$1.07B
| $223K | ﹤0.01% |
+80,205
| New | +$223K |
|
3989
SIGA Technologies
SIGA
$639M
| $223K | ﹤0.01% |
30,289
+6,549
| +28% | +$48.2K |
|
3990
Ultra Clean Holdings
UCTT
$1.25B
| $223K | ﹤0.01% |
+6,718
| New | +$223K |
|
|
BCEL
3991
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| $223K | ﹤0.01% |
278,322
+61,550
| +28% | +$49.3K |
|
3992
AC Immune
ACIU
$246M
| $222K | ﹤0.01% |
+108,806
| New | +$222K |
|
|
DDI
3993
DoubleDown Interactive
DDI
$467M
| $222K | ﹤0.01% |
26,227
+9,227
| +54% | +$78.1K |
|
3994
Union Bankshares
UNB
$118M
| $222K | ﹤0.01% |
9,469
+353
| +4% | +$8.28K |
|
|
JPS
3995
DELISTED
Nuveen Preferred & Income Securities Fund
JPS
| $222K | ﹤0.01% |
+32,614
| New | +$222K |
|
|
AGEN
3996
Agenus
AGEN
$140M
| $221K | ﹤0.01% |
4,691
-8,130
| -63% | -$383K |
|
|
DSM
3997
BNY Mellon Strategic Municipal Bond Fund
DSM
$293M
| $221K | ﹤0.01% |
+38,202
| New | +$221K |
|
3998
Nano X Imaging
NNOX
$256M
| $221K | ﹤0.01% |
29,956
+12,903
| +76% | +$95.2K |
|
3999
Old Republic International
ORI
$9.85B
| $221K | ﹤0.01% |
9,140
-227,117
| -96% | -$5.49M |
|
4000
Avalo Therapeutics
AVTX
$153M
| $220K | ﹤0.01% |
180
-33
| -15% | -$40.3K |
|